As used in the Wholesale Prescription Drug Importation Act:
A. "Canadian supplier" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs;
B. "committee" means the prescription drug importation advisory committee;
C. "department" means the department of health;
D. "eligible prescription drug" means a drug eligible for importation that:
(1) meets the United States federal food and drug administration's standards related to safety, effectiveness, misbranding and adulteration;
(2) does not violate federal patent laws;
(3) is expected to generate cost savings; and
(4) is not a controlled substance;
E. "program" means the wholesale prescription drug importation program; and
F. "state drug wholesaler" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier.
History: Laws 2020, ch. 45, § 2.
Emergency clauses. — Laws 2020, ch. 45, § 11 contained an emergency clause and was approved March 4, 2020.
Structure 2021 New Mexico Statutes
Chapter 26 - Drugs and Cosmetics
Article 4 - Wholesale Prescription Drug Importation
Section 26-4-3 - Advisory committee created; membership; duties.
Section 26-4-4 - Wholesale prescription drug importation program created.
Section 26-4-5 - Monitoring for anti-competitive behavior.
Section 26-4-6 - Federal compliance.
Section 26-4-7 - Implementation.
Section 26-4-8 - Annual reporting.
Section 26-4-9 - Wholesale prescription drug importation fund.
Section 26-4-10 - Countries other than Canada allowed by federal law.